Filing Details
- Accession Number:
- 0001104659-20-124504
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 17:31:26
- Reporting Period:
- 2020-11-10
- Accepted Time:
- 2020-11-12 17:31:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1175151 | Cytosorbents Corp | CTSO | Surgical & Medical Instruments & Apparatus (3841) | 980373793 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1368152 | Al Kraus | C/O Cytosorbents Corporation 7 Deer Park Drive, Suite K Monmouth Junction NJ 08852 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-10 | 8,000 | $3.45 | 133,046 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-10 | 8,000 | $8.00 | 125,046 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-10 | 8,000 | $0.00 | 8,000 | $3.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-01-06 | No | 4 | M | Direct |
Footnotes
- These shares were sold in multiple transactions and multiple lots for the same price for this sale have been combined.
- Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 55,746 shares of common stock owned by the reporting person.
- These options were originally granted to Mr. Kraus on January 6, 2011 as compensation for services rendered. The grant became fully vested on January 6, 2020.
Billionaire Hedge Funds
